Alzheimer’s team tackles a daunting R&D field with a new game plan
The drug is tramiprosate, which flunked a big study back in 2009. It’s been rebuilt, so to speak, so it can be delivered through the gut in such a way as it can deliver a higher dose where it’s needed in the brain.
As quoted from fiercebiotech.com. Read the full article here